Eylea Treatment for Macular Degeneration

A new drug has been developed as a treatment for macular degeneration.  The drug named Eylea will compete directly with Lucentis, the current leading treatment for the eye disease. It is expected … [Read more...]

Avastin Improves Vision in Wet Macular Degeneration Patients

Avastin treatments have been shown to improve vision in patients with long term low vision secondary to wet macular degeneration.  Designed initially as a cancer drug, Avastin has been used to treat … [Read more...]

Off-Label Avastin for Macular Degeneration – An Update

The use of Avastin to treat eye disease such as macular degeneration has increased despite being originally designed for treating cancer. While many proponents have indicated that the use of Avastin … [Read more...]

New Treatment for Macular Degeneration

Macular degeneration has been heavily researched in recent years, with many scientists and doctors looking for viable treatments for the eye disease.  Recently, scientists have combined a new method … [Read more...]

Macular Degeneration Treatment Lucentis

Lucentis (ranibizumab) is an FDA approved drug for treating wet macular degeneration.  Derived from the cancer drug Avastin, Lucentis is developed by GenenTech and is referred to as a humanized … [Read more...]